{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:29:00Z","timestamp":1787869740363,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T00:00:00Z","timestamp":1276473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T00:00:00Z","timestamp":1276473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/bmt.2010.137","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T12:08:50Z","timestamp":1276517330000},"page":"344-349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT"],"prefix":"10.1038","volume":"46","author":[{"given":"N","family":"Cantoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gerull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Halter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Buser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Tsakiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gratwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,14]]},"reference":[{"key":"BFbmt2010137_CR1","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1182\/blood.V98.13.3569","volume":"98","author":"G Socie","year":"2001","unstructured":"Socie G, Clift RA, Blaise D, Devergie A, Ringden O, Martin PJ et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569\u20133574.","journal-title":"Blood"},{"key":"BFbmt2010137_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/BF02906128","volume":"16","author":"M Hassan","year":"1999","unstructured":"Hassan M . The role of busulfan in bone marrow transplantation. Med Oncol 1999; 16: 166\u2013176.","journal-title":"Med Oncol"},{"key":"BFbmt2010137_CR3","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood.V84.6.2036.2036","volume":"84","author":"RA Clift","year":"1994","unstructured":"Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036\u20132043.","journal-title":"Blood"},{"key":"BFbmt2010137_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00000421-199006000-00009","volume":"13","author":"R Brodsky","year":"1990","unstructured":"Brodsky R, Topolsky D, Crilley P, Bulova S, Brodsky I . Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan\/cyclophosphamide preparative regimen. Am J Clin Oncol 1990; 13: 221\u2013225.","journal-title":"Am J Clin Oncol"},{"key":"BFbmt2010137_CR5","doi-asserted-by":"publisher","first-page":"881","DOI":"10.7326\/0003-4819-112-11-881_1","volume":"112","author":"G Vassal","year":"1990","unstructured":"Vassal G, Hartmann O, Benhamou E . Busulfan and veno-occlusive disease of the liver. Ann Intern Med 1990; 112: 881.","journal-title":"Ann Intern Med"},{"key":"BFbmt2010137_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.bmt.1700994","volume":"20","author":"P Ljungman","year":"1997","unstructured":"Ljungman P, Hassan M, Bekassy AN, Ringden O, Oberg G . High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients. Bone Marrow Transplant 1997; 20: 909\u2013913.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010137_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/sj.bmt.1703896","volume":"31","author":"C Nilsson","year":"2003","unstructured":"Nilsson C, Aschan J, Hentschke P, Ringden O, Ljungman P, Hassan M . The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 31: 429\u2013435.","journal-title":"Bone Marrow Transplant"},{"issue":"4A","key":"BFbmt2010137_CR8","first-page":"2083","volume":"16","author":"I Buggia","year":"1996","unstructured":"Buggia I, Zecca M, Alessandrino EP, Locatelli F, Rosti G, Bosi A et al. Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo). Anticancer Res 1996; 16 (4A): 2083\u20132088.","journal-title":"Anticancer Res"},{"key":"BFbmt2010137_CR9","first-page":"135","volume":"10","author":"V Meresse","year":"1992","unstructured":"Meresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10: 135\u2013141.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010137_CR10","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2002-06-1860","volume":"101","author":"GB McDonald","year":"2003","unstructured":"McDonald GB, Slattery JT, Bouvier ME, Ren S, Batchelder AL, Kalhorn TF et al. Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 2003; 101: 2043\u20132048.","journal-title":"Blood"},{"key":"BFbmt2010137_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.bbmt.2007.03.012","volume":"13","author":"JS McCune","year":"2007","unstructured":"McCune JS, Batchelder A, Deeg HJ, Gooley T, Cole S, Phillips B et al. Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality. Biol Blood Marrow Transplant 2007; 13: 853\u2013862.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2010137_CR12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.bmt.1702377","volume":"25","author":"M Hassan","year":"2000","unstructured":"Hassan M, Ljungman P, Ringden O, Hassan Z, Oberg G, Nilsson C et al. The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity. Bone Marrow Transplant 2000; 25: 915\u2013924.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010137_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000028359","volume":"60","author":"LD DeLeve","year":"2000","unstructured":"DeLeve LD, Wang X . Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. Pharmacology 2000; 60: 143\u2013154.","journal-title":"Pharmacology"},{"key":"BFbmt2010137_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.bmt.1703615","volume":"30","author":"Z Hassan","year":"2002","unstructured":"Hassan Z, Hellstrom-Lindberg E, Alsadi S, Edgren M, Hagglund H, Hassan M . The effect of modulation of glutathione cellular content on busulphan-induced cytotoxicity on hematopoietic cells in vitro and in vivo. Bone Marrow Transplant 2002; 30: 141\u2013147.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010137_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.exphem.2004.12.003","volume":"33","author":"C Nilsson","year":"2005","unstructured":"Nilsson C, Forsman J, Hassan Z, Abedi-Valugerdi M, O\u2019Connor C, Concha H et al. Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice. Exp Hematol 2005; 33: 380\u2013387.","journal-title":"Exp Hematol"},{"issue":"Suppl 3","key":"BFbmt2010137_CR16","first-page":"S13","volume":"21","author":"JL Ferrara","year":"1998","unstructured":"Ferrara JL . The cytokine modulation of acute graft-versus-host disease. Bone Marrow Transplant 1998; 21 (Suppl 3): S13\u2013S15.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010137_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/intimm\/5.6.565","volume":"5","author":"CS Via","year":"1993","unstructured":"Via CS, Finkelman FD . Critical role of interleukin-2 in the development of acute graft-versus-host disease. Int Immunol 1993; 5: 565\u2013572.","journal-title":"Int Immunol"},{"key":"BFbmt2010137_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4049\/jimmunol.164.2.656","volume":"164","author":"GR Hill","year":"2000","unstructured":"Hill GR, Teshima T, Rebel VI, Krijanovski OI, Cooke KR, Brinson YS et al. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity. J Immunol 2000; 164: 656\u2013663.","journal-title":"J Immunol"},{"key":"BFbmt2010137_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/sj.bmt.1705996","volume":"41","author":"B Sadeghi","year":"2008","unstructured":"Sadeghi B, Jansson M, Hassan Z, Mints M, Hagglund H, Abedi-Valugerdi M et al. The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model. Bone Marrow Transplant 2008; 41: 895\u2013904.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010137_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/bmt.2009.123","volume":"45","author":"G Stussi","year":"2010","unstructured":"Stussi G, Halter J, Tichelli A, Meyer-Monard S, Buser AS, Arber C et al. Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies. Bone Marrow Transplant 2010; 45: 103\u2013109.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010137_CR21","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1002\/cncr.24531","volume":"115","author":"A Gratwohl","year":"2009","unstructured":"Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer 2009; 115: 4715\u20134726.","journal-title":"Cancer"},{"key":"BFbmt2010137_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1600-0609.2009.01249.x","volume":"83","author":"N Cantoni","year":"2009","unstructured":"Cantoni N, Weisser M, Buser A, Arber C, Stern M, Heim D et al. Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortality. Eur J Haematol 2009; 83: 130\u2013138.","journal-title":"Eur J Haematol"},{"key":"BFbmt2010137_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1537-2995.2007.01613.x","volume":"48","author":"D Heim","year":"2008","unstructured":"Heim D, Passweg J, Gregor M, Buser A, Theocharides A, Arber C et al. Patient and product factors affecting platelet transfusion results. Transfusion 2008; 48: 681\u2013687.","journal-title":"Transfusion"},{"key":"BFbmt2010137_CR24","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI . The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005\u20133020.","journal-title":"Blood"},{"key":"BFbmt2010137_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.beha.2008.12.002","volume":"22","author":"DA Tsakiris","year":"2009","unstructured":"Tsakiris DA, Tichelli A . Thrombotic complications after haematopoietic stem cell transplantation: early and late effects. Best Pract Res Clin Haematol 2009; 22: 137\u2013145.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFbmt2010137_CR26","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1056\/NEJM200106143442402","volume":"344","author":"MJ Laughlin","year":"2001","unstructured":"Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815\u20131822.","journal-title":"N Engl J Med"},{"key":"BFbmt2010137_CR27","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1056\/NEJM197504172921605","volume":"292","author":"E Thomas","year":"1975","unstructured":"Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE et al. Bone-marrow transplantation (first of two parts). N Engl J Med 1975; 292: 832\u2013843.","journal-title":"N Engl J Med"},{"key":"BFbmt2010137_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev.me.35.020184.000303","volume":"35","author":"HJ Deeg","year":"1984","unstructured":"Deeg HJ, Storb R . Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med 1984; 35: 11\u201324.","journal-title":"Annu Rev Med"},{"key":"BFbmt2010137_CR29","first-page":"631","volume":"40","author":"L Siekmann","year":"2002","unstructured":"Siekmann L, Bonora R, Burtis CA, Ceriotti F, Clerc-Renaud P, Ferard G et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 1. The concept of reference procedures for the measurement of catalytic activity concentrations of enzymes. Clin Chem Lab Med 2002; 40: 631\u2013634.","journal-title":"Clin Chem Lab Med"},{"key":"BFbmt2010137_CR30","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V85.7.1954.bloodjournal8571954","volume":"85","author":"SJ Scharf","year":"1995","unstructured":"Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA . Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995; 85: 1954\u20131963.","journal-title":"Blood"},{"key":"BFbmt2010137_CR31","first-page":"288","volume":"132","author":"A Wicki","year":"2002","unstructured":"Wicki A, Malik N, Gratwohl A, Tichelli A, Meyer-Monard S, Muller H . Determination of the donor:host blood cell ratio after haematological stem cell transplant by means of semiquantitative detection of short tandem repeat polymorphisms. Swiss Med Wkly 2002; 132: 288\u2013295.","journal-title":"Swiss Med Wkly"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2010137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010137","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T13:13:59Z","timestamp":1648041239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2010137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,14]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BFbmt2010137"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2010.137","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,14]]},"assertion":[{"value":"22 March 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AG and NC received research support from Pierre Fabre SA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}